PAWe're building next generation computational technology that unlocks insights from each sample for doctors to optimize patient outcomes.
Transforming cancer care at all stages of the disease.
GRAIL is a healthcare company focused on detecting cancer early, when it can be cured, through the development and commercialization of pioneering multi-cancer early detection blood tests like Galleri®.
Veracyte, Inc. is a global diagnostics company dedicated to revolutionizing cancer care through innovative genomic testing solutions.
Ataraxis AI is a precision medicine company developing AI-powered diagnostic tools to improve cancer treatment selection and patient outcomes, starting with its flagship product, Ataraxis Breast.
Foundation Medicine is a molecular information company dedicated to transforming cancer care by providing comprehensive genomic profiling tests to identify the molecular alterations in a patient's cancer and match them with relevant treatments and clinical trials.